---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-294445"
form_type: "8-K"
ticker: "OFIX"
cik: "0000884624"
company_name: "Orthofix Medical Inc."
filed_at: "2026-07-02T20:00:15+00:00"
generated_at: "2026-07-02T20:01:06.179910+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CMS withdraws Medicare billing changes for Orthofix bone growth stimulators; reimbursement restored to prior rates

## Summary
- On July 1, 2026, CMS issued revised guidance withdrawing May 18, 2026 billing changes for HCPCS codes E0747, E0748, E0760.
- Orthofix expects average Medicare reimbursement for these codes to return to rates in effect prior to May 18, 2026.
- The reversal follows FDA's April 16, 2026 reclassification of non-invasive bone growth stimulators from Class III to Class II.
- The prior CMS changes had modified billing requirements and Medicare fee schedule treatment; now withdrawn.

## SEC filing metadata
- accession: 0001193125-26-294445
- form_type: 8-K
- ticker: OFIX
- cik: 0000884624
- company_name: Orthofix Medical Inc.
- filed_at: 2026-07-02T20:00:15+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/884624/000119312526294445/0001193125-26-294445-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/884624/000119312526294445/ofix-20260701.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-294445
- JSON: https://secwatch.observer/filing/0001193125-26-294445.json
- Plain text: https://secwatch.observer/filing/0001193125-26-294445.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.